Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS), a $1.78 billion market cap company specializing in biological products, announced ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
More than half of Coloradans have reported being worried about the costs of prescription medications they and their families ...
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) has announced the appointment of Andy Pasternak as Chairman of ...
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
"I'm really excited to see how we're going to be able to use that money to impact families in Baltimore City positively," ...
Medcura, Inc., a leader in innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding, has announced the formation of its Spinal Surgery Advisory Board.
Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial
Most treatments being pursued today to protect against Alzheimer’s disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and ...
Triplebar, a pioneering biotechnology company based in Emeryville which is focused on developing cost effective and effective ...
Launching a private equity fund is an exciting yet daunting endeavor; and a General Partner (GP) Advisory Board can be a ...
Beximco Pharma's parent company, the Beximco Group, has been accused of taking bank loans through fraud over a number of years. Public interest litigation was filed against the company, though it also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback